Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 8 September 2009, doi:10.1136/bmj.b3659
Cite this as: BMJ 2009;339:b3659
Mark Pownall
1 London
| The first 150 words of the full text of this article appear below. |
The American Heart Associations journal Circulation has issued a lengthy correction to a clinical trial at the centre of a libel action directed against a UK cardiologist. It has also replaced the original study with a corrected version on its website.
The correction (Circulation 2009;120:e71-2, doi:10.1161/CIRCULATIONAHA.109.192626) says that the migraine intervention with STARFlex technology (MIST) trial, originally published in March last year (Circulation 2008;117:1397-1404, doi:10.1161/CIRCULATIONAHA.107.727271), had "a number of errors and omissions."
The libel suit, against Peter Wilmshurst, a consultant cardiologist at Shrewsbury Hospital, followed comments he was reported to have made to a cardiology website (http://theheart.org) about the trial, of which he was a joint principal investigator.
The MIST trial aimed to see whether closing a patent foramen ovale with the STARFlex implant would reduce or eliminate migraines.
The legal action was brought by the manufacturer of the STARFlex implant, NMT
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses